KEY POINTS Chronic rhinosinusitis refers to symptomatic inflammation of the nose and paranasal sinuses that has been present for a minimum of 3 months.[1][1] Its true prevalence is difficult to ...

which said it remains committed to brining the drug to patients with the inflammatory condition, which results in the growth of nasal polyps in the nose that can sometimes require surgical ...

Dupilumab, an interleukin-4 receptor antagonist, is expected to decrease the type 2 inflammation seen in bullous pemphigoid.

The "Sinusitis Pipeline Insight Analysis Report" drug pipelines has been added to ResearchAndMarkets.com's offering.The sinusitis treatment pipeline analysis provides an overview of recent ...

Free take-home screening tests for colon cancer will be distributed at several upcoming drive-thru events in Decatur, Jacksonville, Lincoln, Springfield and Taylorville, sponsored by the Regional ...

From digestive conditions to more serious health concerns, discover why medical experts emphasize the importance of not ignoring blood in your stool.

It makes knowing the signs of a developing medical condition and taking steps to prevent it all the more valid. Below, we ...

but the elements of this reaction are probably different as CB proceeds to a fibrotic process and the proliferative bronchiolitis with intraluminal polyps continues as an inflammatory process.

You will be able to get a quick price and instant permission to reuse the content in many different ways. inflammatory neuropathies Guillain-Barré syndrome chronic inflammatory demyelinating ...

Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoidIf approved, Dupixent would be the first and only ...

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025 Priority Review granted based on positive pivotal results ...